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Abstract
Background: This retrospective study evaluated soft-tissue grafting as a surgical treatment option for peri-implantitis
in case of unsuitable basic skeletal morphology of the alveolar bone and lack of keratinized mucosa.
Methods: Twenty-eight patients (21 females, 7 males, at a mean age 59.4 years) were included with a total of 54
implants. All implants showed peri-implantitis and attached keratinized buccal mucosa of ≤2 mm. A surgical procedure
of soft-tissue grafting (STG) was made by inserting an inlay and inlay-onlay transplant. Clinical investigations were
made prior to the STG (baseline) and after 9–180 months (Ø 43 months) including the following parameters: soft-tissue
biotype, skeletal basic morphology of the alveolar bone, width of the peri-implant keratinized mucosa (KM), mobility of
the KM, pocket probing depth (PPD), and bleeding on probing (BOP).
Results: Nearly all patients showed a thin soft-tissue biotype. The analysis of the skeletal basic morphology of the alveolar
bone revealed a narrow apical base in 18 patients, middle base in 7 patients, and broad base in 3 patients. Width of the
KM increased significantly (p < 0.01) from 0.4 ± 0,5 mm to 4.3 ± 1.5 mm after STG and PPD was significantly (p< 0,01)
reduced from 6.3 ± 2,3 mm to 4.1 ± 1.9 mm. A significant reduction (p < 0.01) in BOP was recorded. All patients reported a
clinical improvement of the inflammatory symptoms at follow-up.
Conclusions: The results of this study showed that the STG can be applied successfully as a surgical treatment
of peri-implantitis. It remains unclear whether soft-tissue biotype or the skeletal basic morphology of the
alveolar bone affects the outcome of this surgical treatment.
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Background
With an increasing number of patients with implant-
supported dentures, dentists are increasingly confronted
with diseases of the peri-implant hard and soft tissue [1].
Ten-year survival rates of about 95 % of dental
implants were reported, but a high percentage of these
implants showed peri-implantitis [2, 3]. In this case, the
complications around the implant are so complex that
the mechanic-physical, biological, chemical, and toxico-
logical effects are often difficult to determine.
In addition to the etiologically relevant patient-related
as well dentist-related factors of peri-implantitis,
immunological foreign body response to the implant
material was described [4].
The surgical and non-surgical treatment techniques
are usually based on the peri-implant bone defect
morphology [5, 6].
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Further, important anatomical factors such as the
three-dimensional position of the implant and the result-
ing defect morphology in relation to the cephalometric
basic pattern of the maxilla and the mandible remained
unconsidered. The influence of the structural-biological
factors with regard to the morphology of the peri-
implant soft tissue remains also controversial [7].
Particularly, the quality and quantity of the peri-
implant soft tissue affect significantly the dynamics of
the marginal bone loss [8]. So that an adequate keratinized
mucosa at the implant site leads to a reduced plaque accu-
mulation, a reduced inflammatory mucosal infiltration,
and a pro-inflammatory mediator release [9]. This was
confirmed in an animal study of Benghazi et al., they
showed in their study that in case of missed keratinized
mucosa, bone resorption and prevalence of soft-tissue re-
cession could be reduced through soft-tissue grafting [10].
The aim of this retrospective clinical cohort study is to
evaluate the success of soft-tissue grafting (STG) as a
surgical treatment of peri-implantitis in case of unsuit-
able skeletal basic morphology of the alveolar bone and
the lack of keratinized mucosa. The null hypothesis of
this study is that STG as an exclusive surgical treatment
modality after initial treatment particularly in a case of
thin skeletal basic morphology reduces clinical symp-
toms of peri-implantitis. In cases of an absence of the
skeletal-related, three-dimensional defect, morphology in
a relation to the implant position soft-tissue grafting
seems to be the only reconstructive option. In such
cases, STG allows recession of a peri-implant inflamma-
tory process through stabilization of the peri-implant
soft tissue.
Methods
This study was conducted according to the guidelines of
the ethics committee at the Johann Wolfgang Goethe
University in Frankfurt/Main and strictly followed the
ethical principles of the World Medical Association
Declaration of Helsinki [11]. All patients were in-
formed about the surgical procedure of this study and
signed an informed consent.
Patient population
The selection of the patients was made according to the
data bank of the surgeon. All the patients were referred
to a private clinic and to a department of oral surgery at
the university. Patients who suffered from a peri-
implantitis and were treated with STG were taken into
consideration for this investigation. Patients were con-
tacted by phone to ask for a participation in this study.
From 62 patients, 28 agreed to participate in the
study. The other 34 patients were either not available
by phone or did not agree to participate in the study
for personal reasons.
Exclusion criteria
Patients with the following diseases were excluded from
this study: untreated diabetes mellitus, pregnancy, bis-
phosphonate medication, current orthodontic treatment,
tumors, and infectious diseases (HIV).
A total of 28 patients (21 females, 7 males, at a mean
age 59.4 years) with a total of 54 implants were included.
All patients were given a detailed description of the
treatment procedures and were required to sign an
informed consent form.
There was a total of 20 implants (13 in maxilla, 7 in
mandible) in the anterior region (from canine to canine)
and 34 implants (20 in maxilla, 14 in mandible) in the
posterior region (up to the first premolar).
All implants suffered from peri-implantitis and showed
attached keratinized buccal mucosa of ≤2 mm. The
definition of peri-implantitis is according to estab-
lished criteria defined when PPD (pocket probing
depth) was >5 mm with or without BOP and with an
annual bone loss of >0.2 mm [3]. The assessment of
peri-implantitis was carried out 1 year after insertion
of the superstructure in this study. The level of bone
loss is according to the criteria of Albrektsson et al.
[12] and the measurement of bleeding on probing
according to the results of the study of Naert et al. [13].
To exclude falsification of a positive diagnosis of peri-
implantitis in case of the absence of bleeding on probing
in addition to excessive pocket probing depth patients’
discomfort and pain were strict incoming criteria for
STG.The following implant systems were used for a
treatment before beginning of this retrospective study:
3 × Biomet 3i (Biomet 3i Deutschland GmbH,
Munich, Germany), 31 × Ankylos (Dentsply IH
GmbH, Mannheim, Germany), 1 × Astra Tech (Dentsply
IH GmbH, Mannheim, Germany), 15 × Camlog (Camlog
Vertriebs GmbH, Wimsheim, Germany), 3 × IMZ
(Friadent, Mannheim, Germany), and 1 × Nobel Replace
select (Nobel Biocare Holding AG, Zürich, Switzerland).
Three patients have bar overdentures (all in maxilla),
three patients telescoping dentures (one in the maxilla
and two in the mandible), and 22 patients fixed
prosthesis; 8 of them have single crown restorations.
The average time from the placement of the implants
to the soft-tissue grafting was 63.2 ± 44.4 months.
Treatment procedures
Non-surgical procedure
A sub-mucosal ultrasonic curettage with ultrasonic
system (Cavitron Ultrasonic scaler® with plastic Scalers,
Dentsply, Mannheim, Germany) was made by all pa-
tients to reduce the inflammation signs as prerequisite
before STG. Furthermore, an antibacterial treatment was
made with a sub-mucosal irrigation using hydrogen
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peroxide 3 % and a local antibiotic application of doxy-
cycline (Ligosan®, Heraeus Kulzer, Hanau, Germany).
If BOP was observed after this non-surgical therapy
and during the following 6 months, a surgical treatment
in terms of a soft-tissue grafting using onlay or inlay-
onlay grafts with respect to the skeletal configuration
was conducted. In case of persistent bleeding or other
significant peri-implant inflammative symptoms, the
protocol prevents, from the ethical point of view, further
peri-implant bone loss, excessive antibiotic administra-
tion, and occurrence of systemic influence of the patho-
logic process. To increase comparability and measure
reliability, all the baseline measurements used in the
statistical analysis were strictly performed after initial
phase. All surgical procedures were carried out by one
surgeon from 1998–2012.
Surgical procedure
The patient (Fig. 1) was anesthetized using (Ultracain®
DS-forte, 1: 100,000, Sanofi-Aventis®, Frankfurt, Germany);
then, a vestibular mucosal flap was raised with a preserva-
tion of a thin soft-tissue layer on the implant surface.
The thickness of the soft-tissue layer that remained on
the implant surface was reduced as much as possible
without perforating this layer or exposing the implant
surface; for this procedure, microsurgical techniques
were used in order to achieve immobility of the trans-
planted keratinized mucosa.
After decontamination of the exposed implant surfaces
with 37 % phosphoric acid gel (Orbis Handels-GmbH,
Münster, Germany), an onlay graft was inserted (Figs. 2
and 3). In cases with highly esthetic sensitive areas, an
inlay-onlay graft was used, which had, in addition to the
keratinized Onlay part, a sub-epithelial connective tissue
part to about 50 % [14–16]. In contrast to inlay-onlay
graft, an onlay graft consists only of keratinized mucosa
with a thickness of approximately 1 mm harvested from
palate as well.
The grafts were harvested from the palate in the
region between the first premolars and second molars.
The desire extension and shape of the graft was trans-
ferred with the help of a simple, tailored paper template
before graft preparation from the palate, so that it fits
exactly into the previously prepared peri-implant defect
and thus accurately simulated the needed amount of
keratinized mucosa. The appropriate connective tissue
grafts were harvested by placing the template on the
palate. The grafts’ sizes were of 5–7 mm width and
7–20 mm length.
Fig. 1 Patient 1: Buccal view of an implant regio 11. Implant
(Camlog Vertriebs GmbH, Wimsheim, Germany, implant 10 years in
situ) with buccal severe peri-implantitis. (8 mm PPD/pus+). Implant is
partly exposed and its position is at the apical base. Reconstruction
using bone grafting is therefore contraindicated. Patient (75 years
old) refused explanation
Fig. 2 Intra-operative view after vestibulum-plasty and positioning
of an onlay-transplant harvested from the palate. The coronal part of
the graft was carefully fixed on the originally existing soft-tissue bridge,
the apical part sits on the tissue that is denudated by vestibulum-plasty.
Part of the exposed implant thread was covered directly by the graft.
The graft was extended 5 mm mesially and 6 mm distally due to
nutritive considerations, and it was fixed in the receptive site
using suturing
Fig. 3 Implant 24 months after soft-tissue grafting. There is no sign
of inflammation and a new mobile keratinized mucosa was built
buccally, (4 mm PPD, Pu-/BOP-). Patient is symptom-free
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The graft was degreased with a micro scissor, and then
reduced with a scalpel to about 1 mm and after that
fixed on the peri-implant lesion in a stable position
using non-absorbable size 5–0 and 6–0 mono sutures.
In case of crater- shaped peri-implant defects, circular
soft-tissue grafts were placed improving soft-tissue qual-
ity and quantity after severe peri-implant infections with
BOP and massive suppuration. Because of diminished
possibility of STG fixation especially in the lower jaw,
onlay grafts were buried with help of deep bucco-lingual
sutures and healing abutments in the immediate postop-
erative period until suture removal. (Figs. 4, 5, 6, 7, 8, 9,
and 10)
The palatal donor site was covered with a preoperative
custom-made (0.5 mm) plastic surgical bandage.
In all patients, a postoperatively systematic antibiotic
medication 3000 mg per day (1000 mg Amoxicillin
Ratiopharm, Ratiopharm GmbH, Ulm, Germany) was
administrated for 7 days.
To reduce postoperative wound swelling and accom-
panying postoperative pain, a glucocorticoid was infiltrated
sub-mucosal at the vestibular region (Dexabene® 4 mg/ml,
Merckle Recordati-KGaA, Darmstadt, Germany).
As analgesic treatment, all patients were given ibupro-
fen (IBU-ratiopharm 400 acute, Ratiopharm GmbH,
Ulm, Germany). The surgical bandage and the suturing
were removed after 7 to 10 days.
Clinical parameters
The first clinical examination was carried out after initial
anti-infective treatment before surgery (baseline), and
the second one was made after a period of 9–180
months (Ø 43 months). In each clinical examination, the
following parameters were assessed: the soft-tissue
biotype, the skeletal biotype was classified, width and
mobility of keratinized mucosa (KM), pocket probing
depth (PPD), and bleeding on probing (BOP) as well.
The soft-tissue biotype was determined prior to the
STG [17]. Differences were made between thick biotype
and thin biotype. During this investigation, the transpar-
ency of the mucosa specified the suitable category when
the periodontal probe was inserted into the sulcus. The
probe was inserted vestibularly into the midpoint of the
sulcus of an existing adjacent tooth (preferably at the
maxillary central incisor), and by translucency, it was
characterized as a thin biotype. A thick biotype was
characterized if color impermeability through the mu-
cosa was recognized.
Furthermore, the basic skeletal morphology of the al-
veolar bone was determined based on the classification
of Cawood and Howell [18]. This was manually detected
at the mandibular symphysis with a dental caliper (Caliper
according to Beerendonk®, DCV instruments Seitingen-
Oberflacht, Germany).
A classification as a broad apical base was made when
the thickness of the jaw at the apical region in oral-
vestibular direction was bigger than the thickness of the
jaw at the marginal area of a natural tooth. A middle
base was classified, when the thickness of the jaw had
Fig. 4 Female patient with severe peri-implantitis in regions 35, 36,
37. PPD ≥7 mm and BOP with suppuration and fistula 36, deficient
keratinized mucosa due to hard tissue augmentation 5.5 years ago
Fig. 5 Crater-shaped peri-implant defects. Granulation tissue was
removed followed by peri-implant osteotomie with the objective of
optimizing subsequent soft-tissue transplantation
Fig. 6 Free onlay graft harvested from the palate with perforations
for sulcus formers
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the same dimension at the two regions mentioned above
and when the jaw at the apical region was thinner than
it was at the marginal region of a natural tooth, then it
was classified as narrow. If the mandibular symphysis
was edentulous, the detection of skeletal biotype was
performed at the maxillary anterior region. A schematic
overview of various exemplary forms of the apical bases
in the symphysis region is shown in Fig. 11.
After staining of the soft tissue using the Schiller iodine
solution [19], the width of the KM at each implant was
measured using a periodontal probe at midpoint of the
vestibular surface.
The mobility of the KM was detected using the long
side of the periodontal probe by vertical movement with
slight pressure. According to the mobility of the mucosa,
it was classified as “movable” or as “immovable”. The
worst value per implant and transplant was recorded,
and in cases of more than one implant per patient, the
worst value was recorded.
The PPD measurements were performed using a
periodontal probe (PCP10, Hu-Friedy®, Rotterdam,
Netherlands) with 25 N/mm force application on the
four surfaces (mesial, distal, buccal/vestibular, and
palatal/lingual). To ensure the evaluation in cases of
unclear PPD values, the superstructures were removed,
and PPD was measured. In patients with more than one
implant, the worst PPD value was recorded.
The BOP measurements were made on four surfaces
(mesial, distal, buccal/vestibular, and lingual/palatal) using
the modified sulcus bleeding index by Lange et al. [20].
In addition, the suppuration was detected. The worst
value per implant was recorded, and in cases of more
than one implant per patient, the worst value was noted.
Follow-up
Nine to one-hundred eighty months after STG, the follow-
ing clinical parameters were assessed again: width and
mobility of keratinized mucosa (KM), pocket probing
depth (PPD), bleeding on probing (BOP), and suppuration
(pos./neg.). All the patients enrolled in a regular mainten-
ance program during the follow-up period.
Fig. 7 Free onlay graft try in fixed by sulcus formers after vestibular
plasty at the lingual and buccal site
Fig. 8 Free onlay graft buried by lingual and buccal split flap
mucosa in the immediate postoperative time
Fig. 9 Postoperative examination after 2 weeks, perfect integration
of free onlay graft with retracted wound margins at the lingual and
buccal site
Fig. 10 Clinical situation 2.5 years after soft-tissue transplantation
without signs of inflammation
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Statistical analysis
Collected data were documented anonymously using
the Excel program (Microsoft©) and assessed using
the statistical program SPSS 16.0 (SPSS Inc., Chicago,
Illinois, USA).
For group comparisons and paired comparisons,
paired t tests were applied with an error probability
limit of 0.05. A linear regression analysis was per-
formed as well.
Results
All 28 patients were examined at baseline and after a
period of time between 9 to 180 months. No implant
was lost during this study. The soft-tissue biotype was
thin in 26 of 28 patients and 2 patients as thick catego-
rized. The analysis of the skeletal base morphology
showed that 18 patients had a narrow base, 7 patients
had a middle base, and 3 had a broad apical base.
The mean width of the KM was 0.4 ± 0.5 mm per
implant before STG, and it was significantly (p < 0.01)
improved to 4.3 ± 1.5 mm. Prior to the STG, 34 of 54
implants showed no keratinized mucosa, and 20
implants showed keratinized mucosa ≤1 mm. At the
second measurement (follow-up), 16 implants showed
KM of ≤3 mm and 38 implants showed 4–7 mm KM
(Fig. 12).
High mobility of the keratinized mucosa was docu-
mented in all implants before STG. At the follow-up, 16
Fig. 11 Schematic illustration of the apical base in the mandibular symphysis. A semi-quantitative measurement was made in this area. The vertical red
lines represent the width of the alveolar bone in the apical region of the tooth/implant
Fig. 12 The width of the KM before and after STG. t test showed significant increase in KM width
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implants had no mobility of the KM, and 12 implants
showed slight mobility.
The mean PPD before soft-tissue augmentation was
6.3 ± 2.3 mm, and it was improved significantly (p <
0.01) to 4.1 ± 1.9 mm (Fig. 13). Prior to STG, 35 im-
plants showed PPD of 4–6 mm, and 19 implants had
PPD of ≥7 mm. To the time of the follow-up, the
PPD was ≤3 mm at 19 implants, 4–6 mm at 30 im-
plants, and ≥7 mm at 5 implants.
At baseline, suppuration could be detected in 11 pa-
tients but at follow-up only in 3 patients (Fig. 14).
The BOP was significantly (p < 0.01) reduced after
grafting, it was observed in 23 implants at baseline but
at the follow-up only in 8 implants (Fig. 14).
Due to the wide range of the follow-up period
(Ø 43 months), we underwent a stratification of the
patients cohort. They were subdivided into three time in-
tervals. First group: 6–12 month follow-up (n = 7), second
group 13–36 month follow-up (n = 10), and third
group >36 month follow-up (n = 11).
The distribution of patients was as follows: in the first
group, four patients = none BOP, one patient =moderate
BOP, two patients = BOP with suppuration; in the
second group, eight patients = none BOP, two patients =
moderate BOP; in the third group, eight patients = none
BOP, two patients = moderate BOP, one patient = BOP
with suppuration.
At baseline, eight patients complained about signifi-
cant discomfort and six patients about slight pressure
pain or burning when the area of the lesion was
touched.
At follow-up, all patients were pain-free and declared
a subjective stable feeling at the implant region. The
positive feeling after therapy was described as follows:
“stable mucosa”, “less sensitive to pain”, “absence of
the food niche”, “cleaning is easier and”, “no more
taste of pus”.
Discussion
Until now, no methodology has been established as a
gold standard approach for the treatment of peri-
implantitis. The surgical phase comprises flap surgery or
utilizing either resective or regenerative techniques.
However, the selection criteria for the application of
these different methods are not clearly defined.
The flap surgery with degranulation of the bony defect,
decontamination of the implant surface, and postopera-
tive antibiotic therapy could not achieve long-term
stability [21]. In resective therapies, such as modeling
osteoplasty, the success of the treatment depends on
both the initial defect depth [22] and beginning of the
disease [23]. Furthermore, the implantoplasty has been
applied to smooth the supra-crestal implant surfaces [24].
The regenerative therapies aim to achieve re-
osseointegration of implants, and it can be used with
different materials. Long-term results are still unavail-
able for both of the resective and the regenerative
methods, and therefore, it is still open as to which
method is preferable. From a clinical point of view,
these results are frustrating, and so they lead to the search
for other surgical techniques, which can be used in com-
bination with the above-mentioned methods in a certain
decision-making process.
In the literature, there are no similar studies to com-
pare with the present study. The results of the measured
clinical parameters prove clearly that STGs can be
Fig. 13 Results of the PPD before and after STG showing a significant reduction in PPD measurements (p < 0.01)
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applied for treatment of peri-implantitis particularly in
cases of unfavorable bone defect morphology. This is the
situation when the position of the planned implant is
inaccurate in or outside the skeletal base of the alveolar
bone. The soft-tissue grafting procedure seems to be
reasonable from a palliative point of view because the
peri-implant recurrent inflammatory symptoms lead
to explantation with superstructure loss which affects
the quality of life for patients.
Besides the soft-tissue biotype, the basic skeletal
morphology of alveolar bone could be, therefore, a risk
factor for the development of peri-implant disease and
could also be a key factor for the successful treatment of
peri-implantitis using soft-tissue grafting. The fact, that
in the present cohort study approximately 65 % of pa-
tients have narrow apical base and only 10 % showed a
broad base, lead to the suggestion that a narrow skeletal
configuration of the upper and lower jaw as class IV
according to Cawood and Howell [18] can be seen as an
additional possible risk factor for the development of
peri-implant inflammatory lesions. The reduced bone
dimension above ossointegrated implants with respect to
buccal and lingual site in case of narrowing with reduced
bone vascularization especially in case of dense bone
could be responsible for progressive bone loss and
superinfection in such unfavorable skeletal configur-
ation. In the literature, there are no references confirm-
ing that with certain skeletal conditions higher incidence
rates can be expected. It is therefore advisable that
future clinical trials consider this feature as a clinical
evaluation criterion to validate this observation with
clinical data. In recent years and especially in orthodon-
tics, it is actively discussed that the development of the
alveolar bone at different basic skeletal constitutions has
a significant relation to the application of forces. It was
found that fenestrations and dehiscences at orthodontic-
ally moved teeth will mainly be determined by the
skeletal morphology, the corresponding growth pattern,
and the bite situation [25, 26]. For example, patients
with a horizontal skull structure and a broad apical al-
veolar bone base showed quantitatively less fenestrations
and dehiscences of teeth than patients with a vertical
skull structure and concomitant thin apical bone base.
The importance of the position of the implant in relation
to the skeletal basic morphology of the alveolar bone as
a risk factor is still not clear. Further risk analysis using
the predictive value of anatomical factors in relation to
cephalometric basic pattern of the maxilla and mandible
in the development of the peri-implantitis is advisable.
Similar to the fact that peri-implant lesions are quite
different from periodontitis is the reaction behavior of
the alveolar bone adjacent to the teeth completely differ-
ent from its behavior at the implant sites. Although, it
can be accepted that fenestrations and dehiscences occur
at implants in the form of severe peri-implant inflamma-
tory defects when the implants are set at or even outside
the bone base. In this case, hardly reconstructable peri-
implant defect morphology will result due to the 3D
missed bone.
In spite of the fact that the quality and quantity of the
peri-implant soft tissue has a very important effect on
the marginal peri-implant bone loss [10, 27–30], there
are no approaches in the literature for the soft-tissue
grafting as a therapeutic method which can be used
alone after initial treatment. The present study showed
that in most cases and even by undesired peri-implant
defect morphologies, stabilization of the soft tissue and
reduction of the peri-implant inflammatory process
could be achieved.
The reduced mobility of the soft tissue achieved in this
study allows the conclusion that the presented method-
ology is strongly technical and surgeon sensitive. The
degree of preoperative inflammatory activity did not
correlate with the degree of immobilization of the KM
gained, which means that the degree of postoperative
gained immobility was not dependent on the severity of
preoperative bleeding. The high proportion of patients
with a thin mucosal biotype and the achieved changes in
Fig. 14 Results of BOP and suppuration before and after STG showing a significant reduction (p < 0.01)
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the local peri-implant biotypes emphasize this observa-
tion. In this context, the consequent anti-infective treat-
ment performed before STG is of prime importance for
patient outcome. Reduction of local bleeding and vulner-
ability allows proper transplant procedure and a reliable
healing process.
It remains unsettled whether patients with a thick
biotype will be less responsive to soft-tissue grafting than
patients with a thin biotype. Therefore, it is recom-
mended to conduct such investigation with a control
group of patients with thick biotype in order to be able
to answer this question. It is also recommended to
investigate other approaches in larger cohort constitu-
tional variations with different phenotypic forms of
intra-oral soft and hard tissues of different ethnic groups
similar to the study by Patil et al. [31].
According to the follow-up data that were stratified,
it revealed that in the shorter period of follow-up,
BOP could be rather present than in the longer heal-
ing period (>12 month, 2nd and 3rd group). The
reason for that could be the slow-going scarification
of the transplanted mucosa for many years. Depend-
ing on the increasing rigidity of the transplanted
keratinized mucosa, the irritation of the mobile mu-
cosa decreases and the signs of inflammation (BOP)
is reduced. Besides the weak data, it seems that the
new mucosa has to undergo a maturing process be-
fore a significant reduction of inflammatory symptoms
occurs. Nevertheless, the study design cannot clearly
answer this question; further controlled prospective
trials have to be performed.
The reduction of PPD was possible through the
stabilization and immobilization of the soft tissue ac-
companied by the establishment of an inflammation-free
soft-tissue cuff, more than through the bone regener-
ation. The significant reduced values of BOP values
are in accordance with the results of Boynueğri et al.
[9] which confirmed that an adequate width of kera-
tinized mucosa reduced plaque accumulation, inflam-
matory mucosal infiltration, and pro-inflammatory
mediator release. Whether the STG at dental im-
plants finally influences crestal bone changes remains
unclear until now. Further controlled clinical trials
with regular x-ray evaluation would be of tremen-
dous interest.
Conclusions
Considering the results of this retrospective study, it can
be summarized that soft-tissue grafting as an additional
surgical therapy option can be integrated in the treat-
ment concept of peri-implantitis. The results showed as
well that with certain clinical morphological conditions,
the soft-tissue grafting can enhance a successful surgical
treatment of peri-implantitis. It can be accepted as well
that the implant system, and thus, the implant design
has no direct influence on the indication of STG.
The soft-tissue grafting procedure seems to be
reasonable from a palliative point of view because the
peri-implant recurrent inflammatory symptoms lead
to explantation with superstructure loss which affect
the quality of life for patients.
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